Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes

Area of Science:

• Endocrinology
• Nephrology
• Metabolic Disorders

Background:

• Conflicting data exist regarding uric acid levels in type 2 diabetes mellitus.
• Elevated serum uric acid is typically associated with hyperinsulinemia and impaired glucose tolerance.
• Low uric acid levels have also been observed in diabetic patients, creating a complex picture.

Purpose of the Study:

• To evaluate the relationship between uric acid levels and metabolic parameters in type 2 diabetes patients.
• To assess the association of uric acid with creatinine clearance and albumin excretion rate.
• To clarify the role of uric acid in the context of metabolic control and diabetic complications.

Main Methods:

• A cohort of type 2 diabetic patients was studied.
• Uric acid levels were measured and correlated with various metabolic parameters.
• Statistical analyses, including multiple regression and logistic regression, were performed to adjust for confounding factors like age, sex, and diabetes duration.

Main Results:

• Hyperuricemic patients exhibited higher BMI, blood pressure, triglycerides, albumin excretion rate, and C-peptide levels.
• Lower high-density lipoprotein (HDL)-cholesterol, creatinine clearance, and glycated hemoglobin (HbA1c) were observed in hyperuricemic individuals.
• Uric acid levels were independently associated with hypertension, metabolic syndrome, and albuminuria after adjustments.

Conclusions:

• Hyperuricemia in type 2 diabetes is linked to insulin resistance syndrome and potentially earlier or faster progression of nephropathy.
• Hypouricemia is associated with worse metabolic control, hyperfiltration, and a later or slower progression of nephropathy.
• Uric acid levels provide insights into metabolic status and renal health in type 2 diabetes.